Cancer cases have been rising over the years and according to the statistics, the number of people living with cancer […]

In a new study, researchers report that they have dramatically broadened the potential targets of CAR-T therapy – their engineered T-cells attack a variety of solid-tumour cancer cells from humans and mice.

The purpose of this study was to develop an approach for the acquisition and processing of macromolecule information to optimize metabolite quantification accuracy and precision.

This review addresses the magnitude of the problem of diabetes, prevalence and cardiovascular complications of DM in the Gulf Cooperation Council (GCC) countries. Further, the review also highlights the causes, guideline implications, and prevention measures for DM control in the GCC countries.

Cancer therapies can affect the whole cardiovascular system, but these cardiotoxic effects are generally reported as changes in left ventricular (LV) ejection fraction. The most common cardiovascular adverse effects are LV dysfunction and heart failure (HF). Other adverse effects include hypertension, acute coronary syndromes, thromboembolic events, rhythm disturbances, and valvular and/or pericardial disease. Hence, prediction, early recognition, and timely management of cardiovascular complications in patients with cancer are gaining importance. This need gave birth to the concept of interdisciplinary cardiology-oncology (cardio-oncology) care delivered through teams of cardiologists, oncologists, and hematologists.